Food and Drug Administration clearance is imminent for several advanced gamma camera options developed by Hitachi Medical Systems America. The Twinsburg, OH, vendor has already received 510(k) clearance for a 5/8-inch crystal option, and is
Food and Drug Administration clearance is imminent for several advanced gamma camera options developed by Hitachi Medical Systems America. The Twinsburg, OH, vendor has already received 510(k) clearance for a 5/8-inch crystal option, and is awaiting the agencys word on nonuniform attenuation correction and coincidence detection options, according to Gary Enos, general manager of the unit.
The upgrades are Hitachis final touches that will make its premium SpectraDigital V250DSP camera a full-featured system capable of high-energy imaging. Hitachi will highlight the options at next months Society of Nuclear Medicine meeting in Los Angeles.
Hitachi will also have its hands full explaining the nuclear medicine units direction in light of the companys new relationship with ADAC Laboratories of Milpitas, CA. Earlier this month, Hitachi announced that it would halt development of new gamma cameras in favor of distributing ADAC systems in Japan (SCAN 5/12/99). Hitachi is reviewing its nuclear business in light of the ADAC relationship, Enos said.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.